Comparison of Evaluation Scales for Trial Administration of Proton Pump Inhibitor for Suspected Laryngopharyngeal Reflux Disease

2012 ◽  
Vol 63 (2) ◽  
pp. 217-217
Author(s):  
K. Hosokawa ◽  
M. Ogawa ◽  
R. Mochiduki ◽  
T. Iwahashi ◽  
H. Sasai ◽  
...  
Keyword(s):  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Laryngopharyngeal Reflux Disease

Influence of Age on Treatment with Proton Pump Inhibitor in Patients with Laryngopharyngeal Reflux Disease

2013 ◽  
Vol 149 (2_suppl) ◽  
pp. P207-P207
Author(s):  
Young-Chan Lee ◽  
Seung-Woo Kim ◽  
Kee-Hwan Kwon ◽  
Young Gyu Eun
Keyword(s):  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Laryngopharyngeal Reflux Disease

A Randomized Clinical Trial of Proton Pump Inhibitors Combined with Traditional Chinese Medicine in the Treatment of Laryngopharyngeal Reflux Disease

2021 ◽  
Author(s):  
Feng Pei ◽  
Wei Jia Hu ◽  
Yi Nan Mao ◽  
Yu Liang Zhao
Keyword(s):  
Proton Pump ◽  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Short Form ◽  
Therapeutic Effects ◽  
Reflux Symptom Index ◽  
Symptom Index ◽  
Laryngopharyngeal Reflux Disease ◽  
Group A ◽  
Group B

Background:To explore whether combined with TCM based on classical proton pumpinhibitors PPIs therapy can achieve better efficacy for patients withlaryngopharyngeal reflux disease. Methods: There were 150 laryngopharyngeal refluxpatients enrolled and divided into three groups randomly, with 50 cases in each group.Patients in group A were treated with the proton pump inhibitor (PPI) lansoprazole.Patients in group B were treated with lansoprazole combined with Banxia Houpudecoction, and patients in group C were treated with acupuncture treatments and acombination of Chinese and Western medicine. The reflux symptom index (RSI), refluxfinding score (RFS), and quality of life (36 item short form health survey questionnaire)were assessed before and 4 and 8 weeks after treatment. Results: The RSI and RFSscores of the three groups were significantly reduced after treatment (P < 0.001). Ingroup B and C, they were lower than in group A at 8 weeks (P < 0.01). The SF 36 scoreof 3 groups increased after treatment. At both 4 and 8 weeks (P < 0.001), and patientsin groups B and C scored higher than patients in group A (P < 0.001). The total effectiverate of group B and group C was higher than that of group A (P < 0.05). Conclusion:All three treatments have therapeutic effects on the disease, but the efficacy of a PPIalone is not as good as the combined treatments’ efficacies. Moreover, PPI combinedwith Banxia Houpu decoction and/or acupuncture treatment substantially affects lifeimprovement.

Effects of Proton Pump Inhibitors in Patients with Laryngopharyngeal Reflux Disease

2011 ◽  
Vol 58 (110-111) ◽  
Author(s):  
Toshimi Chiba ◽  
Norihiko Kudara ◽  
Yukito Abiko ◽  
Masaki Endo ◽  
Kazuyuki Suzuki ◽  
...  
Keyword(s):  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Laryngopharyngeal Reflux Disease

Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease

2017 ◽  
Vol 128 (1) ◽  
pp. 133-137 ◽  
Author(s):  
R. Jun Lin ◽  
Shaum Sridharan ◽  
Libby J. Smith ◽  
VyVy N. Young ◽  
Clark A. Rosen
Keyword(s):  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Laryngopharyngeal Reflux Disease
Sign in / Sign up

Export Citation Format

Share Document